HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reinstitution of neuroleptic treatment with molindone in a patient with a history of neuroleptic malignant syndrome.

Abstract
The decision to reinstitute neuroleptic treatment in patients with a history of neuroleptic treatment is fraught with hazards. A case is reported in which neuroleptic treatment was successfully reintroduced with molindone after previous bouts of neuroleptic malignant syndrome (NMS) with trifluoperazine and thioridazine. Molindone may represent an alternative neuroleptic to consider in patients with a history of NMS, although all neuroleptics including clozapine and molindone may potentially precipitate this syndrome.
AuthorsT Slack, A Stoudemire
JournalGeneral hospital psychiatry (Gen Hosp Psychiatry) Vol. 11 Issue 5 Pg. 365-7 (Sep 1989) ISSN: 0163-8343 [Print] United States
PMID2507394 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Indoles
  • Trifluoperazine
  • Lithium Carbonate
  • Lithium
  • Molindone
Topics
  • Adolescent
  • Bipolar Disorder (drug therapy)
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Electroconvulsive Therapy
  • Humans
  • Indoles (administration & dosage)
  • Intellectual Disability (drug therapy)
  • Lithium (administration & dosage)
  • Lithium Carbonate
  • Male
  • Molindone (administration & dosage)
  • Neuroleptic Malignant Syndrome (etiology)
  • Trifluoperazine (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: